The early identification and management of fatty liver is a critical step in preventing the progression of the disease and its associated complications. Fatty liver, also known as non-alcoholic fatty liver disease (NAFLD), is an increasingly common chronic liver disorder, characterized by excess fat accumulation in the liver. It can be caused by obesity, diabetes, high cholesterol, and high blood pressure. Early identification of fatty liver is essential for timely intervention and effective management. The initial step in screening for fatty liver is a physical examination. A doctor may perform a physical exam, looking for signs of abdominal discomfort, enlarged liver, and signs of chronic liver disease. Blood tests, such as liver function tests, can be used to measure the amount of fat in the liver and can help identify if there is any underlying liver damage. Ultrasound or MRI can be used to visualize the liver and detect any abnormalities in the liver structure. Once fatty liver is identified, it is important to manage the condition to prevent further damage and complications. Lifestyle modifications are the cornerstone of management and should include weight loss, regular exercise, and a healthy diet low in saturated fat, cholesterol, and sugar. Medications, such as statins, may also be prescribed to reduce cholesterol levels. In some cases, a liver transplant may be necessary. It is important to note that fatty liver is a progressive disorder and can progress to cirrhosis and liver failure if left untreated. Early identification and management is key to preventing disease progression and its associated complications. It is important to speak with a doctor if you have any concerns about fatty liver.
Title : Gastroenterology viewed through a glass darkly: An IDI perspective
Gilles R G Monif, University of Florida, United States
Title : The psychology of disorders of gut-brain interactions
Tracy E Hill, Ph.D. & Associates LLC, United States
Title : How epigastric impedance would radically change gastric medicine
John Andrew Sutton, Gastria Ltd, United Kingdom
Title : Role of Pregnancy (P) and breastfeeding on Gallstones (GS) related Acute Pancreatitis (AP)
Alberto Maringhini, La Maddalena, Italy
Title : From the birth of atoms to life: Iodine and caesium, angels and demons of evolutionary biology, in pancreatic cancer and diabetes
Venturi Sebastiano, AUSL-ROMAGNA, Italy
Title : The IL17REL gene encodes a decoy receptor of IL-17 family cytokines to control gut inflammation
Youcun Qian, Shanghai Institute of Nutrition and Health, China